🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 23 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/10/2022 | 207,19 | 208,31 | 205,35 | 205,95 | -0,40% | 1,43% | 151.200 |
| 07/10/2022 | 208,93 | 209,09 | 206,09 | 206,77 | -1,44% | 1,44% | 257.700 |
| 06/10/2022 | 210,85 | 211,12 | 207,97 | 209,80 | -1,06% | 1,49% | 210.900 |
| 05/10/2022 | 214,89 | 215,29 | 210,61 | 212,05 | -1,66% | 2,18% | 303.500 |
| 04/10/2022 | 214,54 | 217,31 | 212,56 | 215,62 | +0,79% | 2,21% | 376.600 |
| 03/10/2022 | 211,56 | 215,71 | 211,36 | 213,93 | +2,17% | 2,06% | 388.300 |
| 30/09/2022 | 208,02 | 210,81 | 207,16 | 209,38 | +0,69% | 1,75% | 418.500 |
| 29/09/2022 | 210,64 | 210,64 | 205,03 | 207,94 | -1,49% | 2,66% | 285.700 |
| 28/09/2022 | 208,01 | 211,43 | 206,00 | 211,08 | +2,52% | 2,61% | 295.900 |
| 27/09/2022 | 203,82 | 207,93 | 203,45 | 205,89 | +1,27% | 2,20% | 249.700 |
| 26/09/2022 | 206,67 | 208,95 | 202,31 | 203,30 | -2,08% | 3,21% | 291.700 |
| 23/09/2022 | 207,01 | 208,49 | 203,08 | 207,62 | -0,17% | 2,61% | 434.200 |
| 22/09/2022 | 206,27 | 210,09 | 201,65 | 207,98 | +1,17% | 4,09% | 291.600 |
| 21/09/2022 | 207,54 | 210,64 | 204,96 | 205,57 | -0,78% | 2,74% | 350.600 |
| 20/09/2022 | 212,68 | 213,03 | 205,07 | 207,18 | -4,48% | 3,74% | 674.900 |
| 19/09/2022 | 217,23 | 218,48 | 214,00 | 216,89 | -0,56% | 2,06% | 295.500 |
| 16/09/2022 | 220,79 | 221,89 | 216,73 | 218,11 | -1,15% | 2,34% | 702.700 |
| 15/09/2022 | 220,00 | 221,66 | 218,29 | 220,64 | +0,67% | 1,53% | 263.800 |
| 14/09/2022 | 217,94 | 219,71 | 216,14 | 219,18 | +1,21% | 1,64% | 499.400 |
| 13/09/2022 | 220,41 | 220,51 | 215,02 | 216,57 | -2,42% | 2,49% | 386.300 |
| 12/09/2022 | 223,48 | 225,10 | 220,84 | 221,94 | -0,69% | 1,91% | 232.200 |
| 09/09/2022 | 223,37 | 224,90 | 222,38 | 223,48 | -0,10% | 1,13% | 244.200 |
| 08/09/2022 | 222,37 | 224,50 | 220,26 | 223,71 | +0,73% | 1,91% | 329.700 |
| 07/09/2022 | 220,88 | 224,81 | 218,97 | 222,08 | -0,12% | 2,64% | 272.400 |
| 06/09/2022 | 222,00 | 224,91 | 220,25 | 222,35 | -0,25% | 2,10% | 303.600 |
| 02/09/2022 | 227,42 | 228,50 | 221,78 | 222,91 | -1,40% | 2,95% | 366.500 |
| 01/09/2022 | 225,09 | 227,45 | 221,52 | 226,07 | -0,24% | 2,63% | 383.100 |
| 31/08/2022 | 219,73 | 230,25 | 208,25 | 226,62 | +3,49% | 10,01% | 1.365.500 |
| 30/08/2022 | 217,16 | 232,06 | 215,54 | 218,97 | +0,68% | 7,61% | 728.900 |
| 29/08/2022 | 213,89 | 219,71 | 212,73 | 217,49 | +1,02% | 3,26% | 245.900 |